|
FY2025
12 months to Dec 28, 2025
|
FY2024
12 months to Dec 29, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 25, 2022
|
|
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net loss | ||||
| Adjustments to reconcile net loss to net cash (used in) provided by operating activities: | ||||
| Depreciation and amortization | ||||
| Amortization of lease acquisition costs | ||||
| Amortization of loan origination fees | ||||
| Amortization of cloud computing arrangements | ||||
| Operating lease cost | ||||
| Loss on disposal of property and equipment | ||||
| Stock-based compensation | ||||
| Impairment and closure costs | ||||
| Non-cash restructuring charges | ||||
| Deferred income tax (benefit) expense | ||||
| Change in fair value of contingent consideration liability | ||||
| Changes in operating assets and liabilities: | ||||
| Accounts receivable | ||||
| Tenant improvement receivables | ||||
| Inventory | ||||
| Prepaid expenses and other current assets | ||||
| Operating lease liabilities | ||||
| Accounts payable | ||||
| Accrued payroll and benefits | ||||
| Accrued expenses and other current liabilities | ||||
| Gift card and loyalty liability | ||||
| Contingent consideration liability | ||||
| Change in fair value of preferred stock warrant liability | ||||
| Other non-current liabilities | ||||
| Deferred rent liability | ||||
| Net cash (used in) provided by operating activities | ||||
| Cash flows from investing activities: | ||||
| Purchase of property and equipment | ||||
| Purchase of intangible assets | ||||
| Acquisition, net of cash acquired | ||||
| Security and landlord deposits | ||||
| Lease acquisition costs | ||||
| Net cash used in investing activities | ||||
| Cash flows from financing activities: | ||||
| Proceeds from preferred stock issuance, net of issuance costs | ||||
| Proceeds from stock option exercise | ||||
| Payment of contingent consideration | ||||
| Payment of loan origination fees | ||||
| Proceeds from exercise of common stock warrants | ||||
| Proceeds from issuance of common stock in connection with initial public offering, net of underwriting discounts and issuance costs | ||||
| Payment associated to shares repurchased for tax withholding | ||||
| Proceeds from issuance of Series F warrants in connection with the initial public offering | ||||
| Proceeds from related party loan | ||||
| Net cash provided by (used in) financing activities | ||||
| Net decrease in cash and cash equivalents and restricted cash | ||||
| Cash and cash equivalents and restricted cash—beginning of year | ||||
| Cash and cash equivalents and restricted cash—end of year | ||||
| Supplemental disclosure of cash flow: | ||||
| Cash paid for interest | ||||
| Non-cash investing and financing activities: | ||||
| Purchase of property and equipment accrued in accounts payable and accrued expenses | ||||
| Acquisition non-cash consideration | ||||
| Initial liability associated with contingent consideration | ||||
| Conversion of redeemable convertible preferred stock to common stock in connection with public company offering | ||||
| Reclassification of warrant liability to APIC in connection with initial public offering | ||||
| Stock Issued | ||||
Loading...